ROCKET LAB CORP (RKLB) FY2026 Q1 Balance Sheet
As of 2026-03-31
Balance Sheet
As of 2026-03-31
Swipe to see the full flow
Chart details
ROCKET LAB CORP (RKLB) FY2026 Q1 Balance Sheet
Balance sheet as of 2026-03-31. The chart shows assets, liabilities and equity at that date.
- Assets
- 2,819,941,000 US dollars
- Current assets
- 1,800,362,000 US dollars
- Non-current assets
- 1,019,579,000 US dollars
- Liabilities
- 555,574,000 US dollars
- Current liabilities
- 402,345,000 US dollars
- Non-current liabilities
- 153,229,000 US dollars
- Equity
- 2,264,367,000 US dollars
- Cash and cash equivalents
- 1,205,499,000 US dollars
- Inventories
- 183,146,000 US dollars
- Marketable securities, current
- 177,852,000 US dollars
- Prepaids and other current assets
- 83,874,000 US dollars
- Contract assets
- 75,036,000 US dollars
- Accounts receivable, net
- 74,955,000 US dollars
- Property, plant and equipment, net
- 343,988,000 US dollars
- Intangible assets, net
- 220,567,000 US dollars
- Goodwill
- 208,738,000 US dollars
- Marketable securities, non-current
- 93,494,000 US dollars
- Right-of-use assets - operating leases
- 90,933,000 US dollars
- Other non-current assets
- 41,719,000 US dollars
- Right-of-use assets - finance leases
- 13,767,000 US dollars
- Restricted cash
- 5,524,000 US dollars
- Deferred income tax assets, net
- 849,000 US dollars
- Contract liabilities
- 241,412,000 US dollars
- Trade payables
- 63,112,000 US dollars
- Employee benefits payable
- 40,720,000 US dollars
- Accrued expenses
- 33,546,000 US dollars
- Other current liabilities
- 23,555,000 US dollars
- Non-current operating lease liabilities
- 85,517,000 US dollars
- Convertible senior notes, net
- 36,869,000 US dollars
- Non-current finance lease liabilities
- 14,568,000 US dollars
- Other non-current liabilities
- 13,207,000 US dollars
- Long-term borrowings, net
- 1,716,000 US dollars
- Deferred income tax liabilities
- 1,352,000 US dollars
- Additional paid-in capital
- 3,324,206,000 US dollars
- Common stock, $0.0001 par value; authorized shares: 2,500,000,000; issued shares: 621,718,750 and 589,525,802 at March 31, 2026 and December 31, 2025, respectively; outstanding shares: 575,767,500 and 543,574,552 at March 31, 2026 and December 31, 2025, respectively
- 58,000 US dollars
- Preferred stock, $0.0001 par value; authorized shares: 100,000,000; issued and outstanding shares: 45,951,250 at March 31, 2026 and December 31, 2025
- 5,000 US dollars
- Treasury stock, at cost; shares: 45,951,250 at March 31, 2026 and December 31, 2025
- 0 US dollars
- Accumulated deficit
- negative 1,056,932,000 US dollars
- Accumulated other comprehensive loss
- negative 2,970,000 US dollars
- Gross equity (calculated)
- 3,324,269,000 US dollars. Net equity plus the magnitudes of its negative contributions equals gross positive equity. The negative contributions enter this reconciliation as add-backs; their filed signs stay negative.
Chart connections
- Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
- Treasury shares and other negative equity contributions reduce equity.

Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG
Product waitlist
Health Check and Teardown for your own company
A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!
